Respiratory Exercises Versus Manual Therapy and Respiratory Exercises in Moderate Smokers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02514161|
Recruitment Status : Completed
First Posted : August 3, 2015
Last Update Posted : December 2, 2015
|Condition or disease||Intervention/treatment||Phase|
|Manual Therapies Respiratory Muscle Training Exercise Therapy Inspiratory Capacity||Other: Inspiratory Muscle training Other: IMT + Manual Therapy and Motor Control Exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||53 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Effects of Manual Therapy and Respiratory Muscle Training on the Maximal Inspiratory Pressure in Moderate Smokers|
|Study Start Date :||June 2015|
|Actual Primary Completion Date :||September 2015|
|Actual Study Completion Date :||November 2015|
Active Comparator: Inspiratory Muscle Training Group (IMT)
The IMT program consisted of supervised and domiciliary exercises.
Other: Inspiratory Muscle training
This protocol will be performed using the Powerbreathe classic level 1 device and Yoga Respiratory Exercises (Pranayama)
Experimental: IMT + Manual Therapy and Motor Control Exercises
The protocol for this group is identical to the previous group with the sole difference that is added a manual therapy (MT) and a motor control exercises (MCE). The MT protocol was performed for 15min, whereas the MCE was 10min. Below it described both protocols:
Other: IMT + Manual Therapy and Motor Control Exercise
The Inspiratory Muscle Training protocol will be performed using the Powerbreathe classic level 1 device and Yoga Respiratory Exercises (Pranayama). Manual Therapy and Motor Control Exercises will consist of joint mobilization/manipulation and exercises in the neck and thoracic regions
- Maximum Inspiratory Pressure [ Time Frame: Change from Baseline in Maximum Inspiratory Pressure at 4 weeks ]The maximum inspiratory pressure (MIP) was measured with a device called Kinetic KH1 Powerbreath (HAB International Ltd., England, UK). This device applies an inspiratory load which provides a resistance. The maneuver was performed in a sitting position. Measuring a minimum of 3 times was performed, recording the highest value.
- Head posture [ Time Frame: Change from Baseline in Head Posture at 4 weeks ]The head posture was measured through the Cervical Range of Motion (CROM) device. This instrument measures physiological movements of the cervical spine and head position. It´s a reliable method of measuring, providing a range of intra-meter reliability from 0.7 to 0.9 and a range of inter-meter reliability from 0.8 to 0.87. The evaluator instructed the patient to sit in a standardized position and assume a natural position of the head and the goniometer was placed over his head to measure the head posture.
- Thoracic kyphosis [ Time Frame: Change from Baseline in Thoracic kyphosis at 4 weeks ]The measurement of the thoracic kyphosis was performed through flexicurve. It is a flexible rule that is molded to the back of the subject in order to replicate the shape of the spine. The flexicurve is a valid and reliable tool. The spinous processes of C7 and T12 were located, subsequently it placed on paper 10x10 to draw the curve and to obtained the index flexicurve.
- Volumes and lung capacities [ Time Frame: Change from Baseline in Volumes and lung capacities at 4 weeks ]The investigators used a simple Spirometry. The Spirometry was performed according to American Thoracic Society criteria with a portable Spirometer model spirobank usb (MIR Rome, Italy). The measures assessed in this outcome were: Forced Vital Capacity (FVC), Forced Expiratory Volume at the First second (FEV1), and Peak Expiratory Flow (PEF). The maneuver was performed 3 times and recording the best one
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02514161
|Centro Superior de Estudios Universitarios La Salle|
|Madrid, Spain, 28023|